Strata Critical Medical, Inc. (SRTA)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $492.15M
Last updated: Nov 17, 2026 at 11:06 AM ET
Strata Critical Medical, Inc. (SRTA) Stock Forecast
Analysts expect Strata Critical Medical (SRTA) to earn -$0.16 per share in the fiscal year ending Dec 31, 2026, on revenue of $289.93M. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 4 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 12.1%.
- Fiscal year ending Dec 31, 2026
- -$0.16
- EPS consensus, revenue $289.93M
- Fiscal year ending Dec 31, 2027
- $0.08
- EPS consensus, revenue $325.07M
- Next report
- Mar 1, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.16 | -$0.17 to -$0.14 | 4 | $289.93M | $289.40M to $290.60M | 4 |
| Dec 31, 2027 | $0.08 | $0.02 to $0.10 | 4 | $325.07M | $315.10M to $330.50M | 4 |
Quarterly Estimates
The EPS consensus falls from $0.02 for the quarter ending Dec 31, 2026 to $0.01 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.02 | $0.01 to $0.03 | 6 | $77.48M | $73.89M to $80.53M | 6 |
| Mar 31, 2027 | $0.01 | -$0.01 to $0.02 | 4 | $79.27M | $76.90M to $82.10M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.09.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.16 | -$0.09 | -$0.09 | -$0.09 | -$0.09 | N/A |
| Fiscal year ending Dec 31, 2027 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | +2248.5% |
| Quarter ending Mar 31, 2027 | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | -50.0% |
Frequently Asked Questions About SRTA
What is the SRTA stock forecast?
Consensus analyst estimates put Strata Critical Medical's EPS at -$0.16 for the fiscal year ending Dec 31, 2026, on revenue of $289.93M. The consensus rating from 4 analysts is Buy.
How do analysts rate SRTA stock?
Of 4 analysts covering Strata Critical Medical, 0 rate it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from SRTA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.16, with estimates from -$0.17 to -$0.14 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.08, with estimates from $0.02 to $0.10 from 4 analysts.
What revenue do analysts expect from Strata Critical Medical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $289.93M, with estimates from $289.40M to $290.60M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $325.07M, with estimates from $315.10M to $330.50M.
How many analysts cover SRTA?
4 analysts rate Strata Critical Medical stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
SRTA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors